Edward B. Garon, MD, MS
- Thoracic Medical Oncology
About
Dr. Garon received his MD degree from the Washington University School of Medicine in 1999, and his internal medicine training at the University of Chicago. He trained in Medical Oncology at UCLA, and joined the UCLA faculty in 2006. He also received a Masters' Degree in clinical investigation at UCLA. In 2008, he was appointed as an Assistant Professor of Medicine at the Geffen School of Medicine at UCLA in the Department of Medicine, Division of Hematology/Oncology and in 2014 he was promoted to Associate Professor of Medicine and he is now Professor of Medicine. Dr. Garon has been awarded the Diana Gordon Jonnson Award for Clinical Excellence in 2015. In addition to his clinical work, he also has an extensive focus in clinical and translational research. He has led studies that have led to FDA approvals of multiple drugs and companion diagnostic tests. He has received multiple foundations grants in addition to peer reviewed grants from governmental agencies, including NIH.
Languages
Education
Medical Board Certification
Fellowship
Residency
Internship
Degree
Recognitions
- Super doctors, Southern California, 2024
- Super Doctors® Southern California, 2022 - 2024
Related Clinical Trials
Locations
Hospital Affiliations
Ronald Reagan UCLA Medical Center
UCLA Santa Monica Medical Center
Medical Services
Areas of Focus
Videos
Research
Interests
Publications
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- L.A. Care
- Medicare Advantage
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of health care plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.
Recognitions
- Super Doctors® Southern California, 2022 - 2024